MANNKIND CORP - 10-Q Filing
MannKind Corp reports Q3 2025 financial results including updates on Blackstone credit facility and United Therapeutics license agreements.
Tickers: $MNKD
MannKind Corp reports Q3 2025 financial results including updates on Blackstone credit facility and United Therapeutics license agreements.
Tickers: $MNKD